Corrigendum
- PMID: 34846172
- DOI: 10.2217/fon-2020-1291c1
Corrigendum
Erratum for
-
Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial.Future Oncol. 2021 May;17(14):1699-1707. doi: 10.2217/fon-2020-1291. Epub 2021 Feb 8. Future Oncol. 2021. PMID: 33554636
Publication types
LinkOut - more resources
Full Text Sources